Trial site
GASTRO JeKa s.r.o.
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis9 trials
- Crohn's disease3 trials
- Coeliac disease1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Sanofi2 trials
- Spyre Therapeutics, Inc.2 trials
- Arena Pharmaceuticals Inc.1 trial
- Celgene1 trial
- Eli Lilly and Company1 trial
- and 4 more
Running trials
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis2 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026